394 related articles for article (PubMed ID: 21330344)
1. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
von Wagner C; Baio G; Raine R; Snowball J; Morris S; Atkin W; Obichere A; Handley G; Logan RF; Rainbow S; Smith S; Halloran S; Wardle J
Int J Epidemiol; 2011 Jun; 40(3):712-8. PubMed ID: 21330344
[TBL] [Abstract][Full Text] [Related]
2. Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England.
von Wagner C; Good A; Wright D; Rachet B; Obichere A; Bloom S; Wardle J
Br J Cancer; 2009 Dec; 101 Suppl 2(Suppl 2):S60-3. PubMed ID: 19956165
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
5. Uptake of Bowel Scope (Flexible Sigmoidoscopy) Screening in the English National Programme: the first 14 months.
McGregor LM; Bonello B; Kerrison RS; Nickerson C; Baio G; Berkman L; Rees CJ; Atkin W; Wardle J; von Wagner C
J Med Screen; 2016 Jun; 23(2):77-82. PubMed ID: 26387824
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.
Morris S; Baio G; Kendall E; von Wagner C; Wardle J; Atkin W; Halloran SP; Handley G; Logan RF; Obichere A; Rainbow S; Smith S; Snowball J; Raine R
Br J Cancer; 2012 Aug; 107(5):765-71. PubMed ID: 22864455
[TBL] [Abstract][Full Text] [Related]
7. Uptake of the English Bowel (Colorectal) Cancer Screening Programme: an update 5 years after the full roll-out.
Hirst Y; Stoffel S; Baio G; McGregor L; von Wagner C
Eur J Cancer; 2018 Nov; 103():267-273. PubMed ID: 30196989
[TBL] [Abstract][Full Text] [Related]
8. Decomposing socio-economic inequality in colorectal cancer screening uptake in England.
Solmi F; Von Wagner C; Kobayashi LC; Raine R; Wardle J; Morris S
Soc Sci Med; 2015 Jun; 134():76-86. PubMed ID: 25917138
[TBL] [Abstract][Full Text] [Related]
9. Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.
Smith SG; Wardle J; Atkin W; Raine R; McGregor LM; Vart G; Morris S; Duffy SW; Moss S; Hackshaw A; Halloran S; Kralj-Hans I; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas M; Counsell N; von Wagner C
BMC Cancer; 2017 Aug; 17(1):543. PubMed ID: 28806955
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
Trials; 2012 Feb; 13():18. PubMed ID: 22348399
[TBL] [Abstract][Full Text] [Related]
11. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
Blanks RG; Benson VS; Alison R; Brown A; Reeves GK; Beral V; Patnick J; Green J
Br J Cancer; 2015 Apr; 112(9):1562-7. PubMed ID: 25742470
[TBL] [Abstract][Full Text] [Related]
12. Inequalities in colorectal cancer screening uptake in Wales: an examination of the impact of the temporary suspension of the screening programme during the COVID-19 pandemic.
Bright D; Hillier S; Song J; Huws DW; Greene G; Hodgson K; Akbari A; Griffiths R; Davies AR; Gjini A
BMC Public Health; 2023 Mar; 23(1):546. PubMed ID: 36949447
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
Dharni N; Armstrong D; Chung-Faye G; Wright AJ
Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
[TBL] [Abstract][Full Text] [Related]
14. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.
Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z
J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822
[TBL] [Abstract][Full Text] [Related]
16. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
Wardle J; von Wagner C; Kralj-Hans I; Halloran SP; Smith SG; McGregor LM; Vart G; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Counsell N; Morris S; Duffy SW; Hackshaw A; Moss S; Atkin W; Raine R
Lancet; 2016 Feb; 387(10020):751-9. PubMed ID: 26680217
[TBL] [Abstract][Full Text] [Related]
17. Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.
van der Vlugt M; Grobbee EJ; Bossuyt PM; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Essink-Bot ML; Spaander MC; Dekker E
Br J Cancer; 2017 Jan; 116(1):44-49. PubMed ID: 27923037
[TBL] [Abstract][Full Text] [Related]
18. Anticipated regret to increase uptake of colorectal cancer screening in Scotland (ARTICS): study protocol for a randomised controlled trial.
O'Carroll RE; Steele RJ; Libby G; Brownlee L; Chambers JA
BMC Public Health; 2013 Sep; 13():849. PubMed ID: 24041309
[TBL] [Abstract][Full Text] [Related]
19. Participation rates for organized colorectal cancer screening programmes: an international comparison.
Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
[TBL] [Abstract][Full Text] [Related]
20. Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing.
van der Meulen MP; Toes-Zoutendijk E; Spaander MCW; Dekker E; Bonfrer JMG; van Vuuren AJ; Kuipers EJ; van Kemenade FJ; van Velthuysen MF; Thomeer MGJ; van Veldhuizen H; de Koning HJ; Lansdorp-Vogelaar I; van Leerdam ME
PLoS One; 2022; 17(2):e0264067. PubMed ID: 35176116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
